Literature DB >> 2203468

Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results.

D F Schaling1, J P van der Pol, M J Jager, M J van Kroonenburgh, J A Oosterhuis, D J Ruiter.   

Abstract

Radioimmunoscintigraphy with monoclonal antibodies (MoAbs) to melanoma associated antigens is a new technique that can be used as an additional test to detect ocular melanomas in clinically difficult cases. Immunoscintigraphy with 99mtechnetium-labelled monoclonal antibody fragments of MoAb 225.28S in 14 patients with melanoma yielded a positive image in only six cases (43%). The expression of high molecular weight melanoma-associated antigen (HMW-MAA) was immunohistochemically assessed in melanoma tissue obtained from these 14 patients to find a possible correlation between the results of immunoscintigraphy and expression of the HMW-MAA. The melanoma tissues were immunohistochemically stained by a sensitive immunoperoxidase procedure with three different monoclonal antibodies to the HMW-MAA: 225.28S, Mel-14, and AMF-6. Expression of the antigen detected by MoAb 225.28S was found in 13 of 14 melanomas; the MoAbMel-14 reacted positively with all 14 melanomas; staining with MoAb AMF-6 was achieved in 10 melanomas. No correlation was found between the immunohistochemical staining results, the conventional histopathological findings, and the immunoscintigraphic results. The immunohistochemical staining results suggest that anti-HMW-MAA MoAbs bind to the melanoma tissue and are therefore potentially suitable for immunoscintigraphy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203468      PMCID: PMC1042203          DOI: 10.1136/bjo.74.9.538

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

Authors:  S Carrel; R S Accolla; A L Carmagnola; J P Mach
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

3.  Monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; G A Molinaro; S Ferrone
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

4.  Characterisation of ocular melanoma with cutaneous melanoma antibodies.

Authors:  J Bomanji; A Garner; J Prasad; D M Albert; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

5.  Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.

Authors:  P G Natali; A Bigotti; R Cavaliere; M R Nicotra; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

6.  Studies of a high molecular weight human melanoma-associated antigen.

Authors:  I Hellström; H J Garrigues; L Cabasco; G H Mosely; J P Brown; K E Hellström
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

7.  Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.

Authors:  J P Brown; R G Woodbury; C E Hart; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.

Authors:  T F Bumol; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

View more
  4 in total

1.  Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?

Authors:  K U Loeffler; P Bräutigam; J C Simon; S R Althauser; C Wuttig; H Witschel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

2.  Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.

Authors:  D F Schaling; J A Oosterhuis; M J Jager; H Kakebeeke-Kemme; E K Pauwels
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

3.  Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.

Authors:  G Modorati; R Brancato; G Paganelli; P Magnani; R Pavoni; F Fazio
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

Review 4.  Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Authors:  Pier Andrea Nicolosi; Alice Dallatomasina; Roberto Perris
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.